In colon cancer, TIMP1 has higher expression levels in tumor tissues and lymph node metastases than in normal tissues, the expression level of TIMP1 in colon cancer is significantly positively correlated with CD4+T cells, macrophages, neutrophils and dendritic cells. Here, CD4 is linked to neoplasm.